The goal of this prospective, interventional, single-center study is to assess whether the
early detection of Influenza with smartwatch algorithms and alerting, rapid testing, and
subsequent Baloxavir treatment demonstrate better post-infection outcomes versus publicly
available- and Centers for Disease Control (CDC)-derived national statistics for equivalent
household populations as well as pediatric kidney, heart, liver, lung transplant recipients
and waitlisted patients.